ProgressImage ProgressImage
Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524715 border-img ISIN Demat INE044A01036 border-img Book Value 93.24 border-img NSE Symbol SUNPHARMA border-img Div & Yield % 0.83 border-img Market Cap ( Cr.) 465195.06 border-img P/E 158.02 border-img EPS 12.27 border-img Face Value 1
Mar 2026
( Cr.)
Mar 2025
( Cr.)
Mar 2024
( Cr.)
Mar 2023
( Cr.)
Mar 2022
( Cr.)
Mar 2021
( Cr.)
SOURCES OF FUNDS :       
Share Capital 239.93239.93239.93239.93239.93239.93
Reserves Total 22130.8323660.3623454.4723508.4324348.0226698.54
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 22370.7623900.2923694.4023748.3624587.9526938.47
Secured Loans 0.000.000.000.000.005.41
Unsecured Loans 13604.7311947.0711226.917790.825074.047352.71
Total Debt 13604.7311947.0711226.917790.825074.047358.12
Other Liabilities 600.16799.841722.961105.451016.381342.13
Total Liabilities 36575.6536647.2036644.2732644.6330678.3735638.72
APPLICATION OF FUNDS :       
Gross Block 20680.5919199.8418251.7417744.6817194.9815812.29
Less : Accumulated Depreciation 13067.5011827.4110515.009033.017482.206143.50
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 7613.097372.437736.748711.679712.789668.79
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 899.391084.20766.11852.91828.641090.38
Producing Properties 0.000.000.000.000.000.00
Investments 12951.5612410.1112429.9712613.2415548.8715537.20
Current Assets, Loans & Advances       
Inventories 4302.273934.133423.623989.193403.743423.42
Sundry Debtors 10166.2311701.548834.167125.024245.166585.24
Cash and Bank Balance 436.97911.05338.39421.28534.96360.98
Loans and Advances 1773.252233.982316.374708.001326.852329.44
Total Current Assets 16678.7218780.7014912.5416243.499510.7112699.08
Less : Current Liabilities and Provisions       
Current Liabilities 5340.126507.513811.447533.367524.566891.41
Provisions 1143.77723.76609.08809.502562.551204.66
Total Current Liabilities & Provisions 6483.897231.274420.528342.8610087.118096.07
Net Current Assets 10194.8311549.4310492.027900.63-576.404603.01
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 1277.962053.681889.791982.841389.471969.40
Deferred Tax Liability 538.56886.04895.27950.451065.43631.95
Net Deferred Tax 739.401167.64994.521032.39324.041337.45
Other Assets 4177.383063.394224.911533.794840.443401.89
Total Assets 36575.6536647.2036644.2732644.6330678.3735638.72
Contingent Liabilities 1326.931990.94941.731087.401031.723083.04
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
imsl-img
close
refresh